Navigation Links
Pharmaceutical Companies On Defense As Post-ACA Implementation Continues
Date:4/22/2013

NASHVILLE, Tenn., April 22, 2013 /PRNewswire/ -- HealthLeaders-InterStudy, the leading provider of managed care market intelligence, studies the collaboration that exists among payers, providers and Accountable Care Organizations (ACOs) across the United States. This web of interconnectedness—which encompasses physicians, physician groups, hospitals, health systems, ACOs, health plan companies, and Managed Care Organizations (MCOs)—varies greatly from market to market. Pharmaceutical companies with granular understanding of these affiliations are better able to scope and target brand opportunities, allocate resources and create meaningful partnerships.

"Now more than ever, it is critical for pharma to know its markets--how decision-makers are aligned and who is changing the face of the local landscape via ACO formation. This is the essence of being a value partner," explains Laura Beerman , Product Manager at HealthLeaders-InterStudy, "specific, actionable knowledge will be vital—especially in situations that require quick decision-making on the move, like prepping for an account call while on the road."

Save the Dates for Our Upcoming Online Open Training!
HealthCare Network Manager: Leverage the Affiliations
June 6, July 11, August 15, September 26  |  2pm Eastern  |  11am Pacific 
HealthLeaders-InterStudy offers Open Training to pharmaceutical company executives that want to find out more about the relationships payers, providers and ACOs share.  For more information about Open Training and to register, please click here or visit our website here.

About HealthCare Network ManagerHealthCare Network Manager is a unique, user-friendly tool that links payer and provider relationships with data sets nationally. It is the first—and only—database of its kind.  In one comprehensive solution, pharmaceutical executives can easily identify the interconnectedness of a particular market, allowing them to save time and make smart decisions. HealthCare Network Manager has a NEW mobile-friendly interface and dynamic search capabilities.

About HealthLeaders-InterStudyHealthLeaders-InterStudy, a Decision Resources Group company, is the authoritative source for managed care data, analysis, and news. HealthLeaders-InterStudy is part of the Market Access Business Unit at Decision Resources Group which also includes Abacus International, Fingertip Formulary, Pinsonault, and PharmaStrat. Find out more at www.hl-isy.com.

About Decision Resources GroupDecision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Lydia Smith

Elizabeth MarshallHealthLeaders-InterStudy

Decision Resources Group 781-993-2594

781-993-2563 lsmith@dresources.com

emarshall@dresources.com


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
2. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc.
3. Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.)
4. Biopharmaceutical Managed Care Strength Closely Intertwined with Marketplace Success
5. ADial Pharmaceuticals Announces Agreement With FDA For Phase III Trial Of AD04 For Alcohol Use Disorder In Patients Of Targeted Genotypes
6. Comparison of Biopharmaceutical Industry Between China and India 2013
7. Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
8. Savara Pharmaceuticals Initiates Phase 2 Clinical Trial of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients
9. Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013
10. Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013
11. Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... , ... People across the U.S. are sharpening their pencils and honing their ... in which patients and their families pay tribute to a genetic counselor by nominating ... of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, ...
Breaking Medicine News(10 mins):